Activity of Moxifloxacin Against Ofloxacin-ResistantMycobacterium Tuberculosis: A Study of Cross-Resistance Between Ofloxacin and Moxifloxacin
Byoung‐Ju Kim, Young Soo Kang, Seung Kyu Park
Abstract
Open-access reader
Byoung‐Ju Kim, Young Soo Kang, Seung Kyu Park
Abstract
Open-access reader
Background : Moxifloxacin is an 8-methoxyquinolone compound which has been shown to have the best activity of the quinolones against M. tuberculosis but there is no literature showing the rate of cross-resistance between moxifloxacin and the other quinolones such as ofloxacin.Therefore, we tested the activity of moxifloxacin against ofloxacin resistant M. tuberculosis by a study of cross-resistance.Methods : We tested MIC's of moxifloxacin and ofloxacin by proportion method against 34 M. tuberculosis isolates showing resistance against ofloxacin at 2.5㎍/㎖ concentration and 13 ofloxacin susceptible isolates from specimens submitted to clinical laboratory of National Masan Hospital from March 2003 to March 2004.Results : For ofloxacin susceptible isolates, MIC50 and MIC90 of ofloxacin were all 1.25㎍/㎖, and MIC50 and MIC90 of moxifloxacin were 0.31㎍/㎖ and 0.63㎍/㎖ respectively.For ofloxacin resistant isolates, MIC50 of ofloxacin was over 10㎍/㎖ and MIC50 of moxifloxacin was 5㎍/㎖ ,MIC90 of ofloxacin and moxifloxacin were all over 10㎍/㎖.The rate of cross-resistance between the two was 67.6%(23/34) at 2.5㎍/㎖ concentration.Conclusions : Moxifloxacin showed activity against 82.4%(28/34) of ofloxacin resistant M. tuberculosis at 10㎍/㎖, but more studies are needed so that moxifloxacin will be used for patient with multi-drug resistant tuberculosis including oflokacin resistance.(
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Background : Moxifloxacin is an 8-methoxyquinolone compound which has been shown to have the best activity of the quinolones against M. tuberculosis but there is no literature showing the rate of cross-resistance between moxifloxacin and the other quinolones such as ofloxacin.Therefore, we tested the activity of moxifloxacin against ofloxacin resistant M. tuberculosis by a study of cross-resistance.Methods : We tested MIC's of moxifloxacin and ofloxacin by proportion method against 34 M. tuberculosis isolates showing resistance against ofloxacin at 2.5㎍/㎖ concentration and 13 ofloxacin susceptible isolates from specimens submitted to clinical laboratory of National Masan Hospital from March 2003 to March 2004.Results : For ofloxacin susceptible isolates, MIC50 and MIC90 of ofloxacin were all 1.25㎍/㎖, and MIC50 and MIC90 of moxifloxacin were 0.31㎍/㎖ and 0.63㎍/㎖ respectively.For ofloxacin resistant isolates, MIC50 of ofloxacin was over 10㎍/㎖ and MIC50 of moxifloxacin was 5㎍/㎖ ,MIC90 of ofloxacin and moxifloxacin were all over 10㎍/㎖.The rate of cross-resistance between the two was 67.6%(23/34) at 2.5㎍/㎖ concentration.Conclusions : Moxifloxacin showed activity against 82.4%(28/34) of ofloxacin resistant M. tuberculosis at 10㎍/㎖, but more studies are needed so that moxifloxacin will be used for patient with multi-drug resistant tuberculosis including oflokacin resistance.(
Key concepts: Ofloxacin, Moxifloxacin, Medicine, Tuberculosis, Microbiology, Antibiotics, Biology, Ciprofloxacin